-
Je něco špatně v tomto záznamu ?
Schizophrenia, the gut microbiota, and new opportunities from optogenetic manipulations of the gut-brain axis
E. Patrono, J. Svoboda, A. Stuchlík
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, přehledy
Grantová podpora
CZ.02.2.69/0.0/0.0/19_074/0016409
European Science Foundation
20-00939S
Grantová Agentura České Republiky
21-16667K
Grantová Agentura České Republiky
NLK
BioMedCentral
od 2005-12-01
BioMedCentral Open Access
od 2005
Directory of Open Access Journals
od 2005
Free Medical Journals
od 2005
PubMed Central
od 2005
Europe PubMed Central
od 2005
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2005-01-01
Open Access Digital Library
od 2005-01-01
Health & Medicine (ProQuest)
od 2009-01-01
Psychology Database (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2005
Springer Nature OA/Free Journals
od 2005-12-01
- MeSH
- lidé MeSH
- mozek MeSH
- optogenetika MeSH
- osa mozek-střevo MeSH
- probiotika * MeSH
- schizofrenie * terapie MeSH
- střevní mikroflóra * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Schizophrenia research arose in the twentieth century and is currently rapidly developing, focusing on many parallel research pathways and evaluating various concepts of disease etiology. Today, we have relatively good knowledge about the generation of positive and negative symptoms in patients with schizophrenia. However, the neural basis and pathophysiology of schizophrenia, especially cognitive symptoms, are still poorly understood. Finding new methods to uncover the physiological basis of the mental inabilities related to schizophrenia is an urgent task for modern neuroscience because of the lack of specific therapies for cognitive deficits in the disease. Researchers have begun investigating functional crosstalk between NMDARs and GABAergic neurons associated with schizophrenia at different resolutions. In another direction, the gut microbiota is getting increasing interest from neuroscientists. Recent findings have highlighted the role of a gut-brain axis, with the gut microbiota playing a crucial role in several psychopathologies, including schizophrenia and autism.There have also been investigations into potential therapies aimed at normalizing altered microbiota signaling to the enteric nervous system (ENS) and the central nervous system (CNS). Probiotics diets and fecal microbiota transplantation (FMT) are currently the most common therapies. Interestingly, in rodent models of binge feeding, optogenetic applications have been shown to affect gut colony sensitivity, thus increasing colonic transit. Here, we review recent findings on the gut microbiota-schizophrenia relationship using in vivo optogenetics. Moreover, we evaluate if manipulating actors in either the brain or the gut might improve potential treatment research. Such research and techniques will increase our knowledge of how the gut microbiota can manipulate GABA production, and therefore accompany changes in CNS GABAergic activity.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22012393
- 003
- CZ-PrNML
- 005
- 20220506130744.0
- 007
- ta
- 008
- 220425s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12993-021-00180-2 $2 doi
- 035 __
- $a (PubMed)34158061
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Patrono, Enrico $u Institute of Physiology of the Czech Academy of Sciences, Videnska, 1830, Prague, 142 20, Czech Republic. enrico.patrono@fgu.cas.cz $1 https://orcid.org/0000000290569537
- 245 10
- $a Schizophrenia, the gut microbiota, and new opportunities from optogenetic manipulations of the gut-brain axis / $c E. Patrono, J. Svoboda, A. Stuchlík
- 520 9_
- $a Schizophrenia research arose in the twentieth century and is currently rapidly developing, focusing on many parallel research pathways and evaluating various concepts of disease etiology. Today, we have relatively good knowledge about the generation of positive and negative symptoms in patients with schizophrenia. However, the neural basis and pathophysiology of schizophrenia, especially cognitive symptoms, are still poorly understood. Finding new methods to uncover the physiological basis of the mental inabilities related to schizophrenia is an urgent task for modern neuroscience because of the lack of specific therapies for cognitive deficits in the disease. Researchers have begun investigating functional crosstalk between NMDARs and GABAergic neurons associated with schizophrenia at different resolutions. In another direction, the gut microbiota is getting increasing interest from neuroscientists. Recent findings have highlighted the role of a gut-brain axis, with the gut microbiota playing a crucial role in several psychopathologies, including schizophrenia and autism.There have also been investigations into potential therapies aimed at normalizing altered microbiota signaling to the enteric nervous system (ENS) and the central nervous system (CNS). Probiotics diets and fecal microbiota transplantation (FMT) are currently the most common therapies. Interestingly, in rodent models of binge feeding, optogenetic applications have been shown to affect gut colony sensitivity, thus increasing colonic transit. Here, we review recent findings on the gut microbiota-schizophrenia relationship using in vivo optogenetics. Moreover, we evaluate if manipulating actors in either the brain or the gut might improve potential treatment research. Such research and techniques will increase our knowledge of how the gut microbiota can manipulate GABA production, and therefore accompany changes in CNS GABAergic activity.
- 650 _2
- $a mozek $7 D001921
- 650 _2
- $a osa mozek-střevo $7 D000087502
- 650 12
- $a střevní mikroflóra $7 D000069196
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a optogenetika $7 D062308
- 650 12
- $a probiotika $7 D019936
- 650 12
- $a schizofrenie $x terapie $7 D012559
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Svoboda, Jan $u Institute of Physiology of the Czech Academy of Sciences, Videnska, 1830, Prague, 142 20, Czech Republic
- 700 1_
- $a Stuchlík, Aleš $u Institute of Physiology of the Czech Academy of Sciences, Videnska, 1830, Prague, 142 20, Czech Republic. ales.stuchlik@fgu.cas.cz
- 773 0_
- $w MED00163303 $t Behavioral and brain functions : BBF $x 1744-9081 $g Roč. 17, č. 1 (2021), s. 7
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34158061 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506130736 $b ABA008
- 999 __
- $a ok $b bmc $g 1789826 $s 1163594
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 17 $c 1 $d 7 $e 20210622 $i 1744-9081 $m Behavioral and brain functions $n Behav Brain Funct $x MED00163303
- GRA __
- $a CZ.02.2.69/0.0/0.0/19_074/0016409 $p European Science Foundation
- GRA __
- $a 20-00939S $p Grantová Agentura České Republiky
- GRA __
- $a 21-16667K $p Grantová Agentura České Republiky
- LZP __
- $a Pubmed-20220425